SLFN11's surveillance role in protein homeostasis
A new research perspective published in Oncoscienceexplores SLFN11's surveillance role in protein homeostasis.
Aug 3, 2022
0
6
A new research perspective published in Oncoscienceexplores SLFN11's surveillance role in protein homeostasis.
Aug 3, 2022
0
6
Investigators from Cedars-Sinai Cancer have identified genetic signatures that could predict whether tumors in patients with bladder and other cancers will respond to immunotherapy. Their results, published today in the Journal ...
Aug 3, 2022
0
5
Glioblastoma multiforme (GBM) is one of the most aggressive, fast-growing tumor types, and the most common cancer of the brain with a median overall survival of approximately 15 months. Despite recent advances in treatment ...
Aug 2, 2022
0
5
Glioblastoma, a rare but deadly brain cancer, is wickedly sturdy. Surgeons remove tumors only to see the cancer come back ferociously. Chemotherapy and radiation therapy have limited effects. About half of patients die within ...
Aug 2, 2022
0
155
The National Comprehensive Cancer Network has published new NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, ...
Jul 27, 2022
0
10
Physician-scientists at the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have discovered that a gene called FOXR2 that is normally turned off in most tissues in the body is activated in at least 70% ...
Jul 22, 2022
0
166
Kidney cancer accounts for only 4% of all cancers in the United States; however, its incidence has more than doubled since 1975, with the most common type being clear cell renal cell carcinoma. While outcomes of patients ...
Jul 8, 2022
0
60
In Norway, more than 3,300 people contract lung cancer every year. It is the second most common form of cancer among both women and men, after breast and prostate cancer, respectively. It also exhibits the highest cancer ...
Jun 30, 2022
0
10
A new study reveals important molecular information that could help scientists develop more effective treatment and prevention strategies for a difficult-to-treat form of melanoma skin cancer.
Jun 23, 2022
0
26
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking to better understand the underlying cause of this variation, a team led by researchers at Baylor ...
Jun 23, 2022
0
6